FIELD: medicine, biotechnology, pharmacy.
SUBSTANCE: invention relates to agents used for treatment of pathological states associated with disorder of synthesis of neuromediating substances. Method involves the development of pharmaceutical composition and a method for it preparing. Pharmaceutical composition represents subcellular synaptosomal fractions: synaptic membranes, "light" synaptosomes and "heavy" synaptosomes prepared from gray matter of cerebral hemispheres from experimental animals based on the goal-seeking modification of humoral mediators of nerve endings transformed to synaptosomes in development and regression of malignant processes. The composition provides inhibiting the growth of tumor cells, to elevate span-life of patients with ascite Ehrlich's sarcoma, breast adenocarcinoma Ca-755, Wolker's carcinosarcoma-256.
EFFECT: valuable medicinal and anti-tumor properties of composition.
12 cl, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
POLYACTIVE TERPENOID SUBSTANCE ABISIL-2, PHARMACEUTICAL COMPOSITION ON ITS BASIS AND WAYS OF ITS APPLICATION | 2007 |
|
RU2338547C1 |
POLYACTIVE RECTAL OR VAGINAL SUPPOSITORIES BASED UPON NATURAL TERPENES ENRICHED WITH MONOTERPENOIDS FOR TREATING AND/OR PROPHYLAXIS OF UROLOGICAL, PROCTOLOGICAL AND GYNECOLOGICAL DISEASES | 2002 |
|
RU2198653C1 |
MEANS FOR TREATMENT OF MALIGNANT ASCITIC TUMOURS | 2011 |
|
RU2464974C1 |
AGENT HAVING ANTI-TUMOUR ACTIVITY | 2023 |
|
RU2819039C1 |
STIMULATOR OF CYTOKIN AND HEMOPOIETIC FACTORS PRODUCTION AND A METHOD OF ITS USING | 1995 |
|
RU2089179C1 |
AGENT FOR REGULATION OF ENDOGENOUS PRODUCTION OF CYTOKINE AND HEMOPOIETIC FACTOR (VARIANTS) AND METHOD OF ITS USING | 1996 |
|
RU2153351C2 |
ACTIVE DRUG INGREDIENT, DRUG, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF DEMYELINATING DISEASES OF LIVING ORGANISM, INCLUDING DISEASE PREVENTION | 2015 |
|
RU2631887C2 |
METHOD OF INHIBITING TUMOUR GROWTH IN MAMMAL | 2018 |
|
RU2713153C1 |
METHOD FOR INDUCTION OF AN ABSCOPAL ANTITUMOR EFFECT IN THE EXPERIMENTAL MODEL OF EHRLICH'S CARCINOMA | 2020 |
|
RU2736120C2 |
COMPLEX ANTI-TUMORAL PRODUCT | 2020 |
|
RU2751776C2 |
Authors
Dates
2005-01-20—Published
2003-02-19—Filed